These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23533809)

  • 1. ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours.
    Srirajaskanthan R; Ahmed A; Prachialias A; Srinivasan P; Heaton N; Jervis N; Quaglia A; Vivian G; Ramage JK
    ISRN Oncol; 2013; 2013():420795. PubMed ID: 23533809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and non-functional pancreatic neuroendocrine tumours: ENETS or AJCC TNM staging system?
    Yang M; Ke NW; Zhang Y; Tan CL; Tian BL; Liu XB; Huang W; Nunes Q; Sutton R
    Oncotarget; 2017 Oct; 8(47):82784-82795. PubMed ID: 29137302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNM staging of pancreatic neuroendocrine tumors: an observational analysis and comparison by both AJCC and ENETS systems from 1 single institution.
    Yang M; Zeng L; Zhang Y; Wang WG; Wang L; Ke NW; Liu XB; Tian BL
    Medicine (Baltimore); 2015 Mar; 94(12):e660. PubMed ID: 25816036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.
    Niederle MB; Hackl M; Kaserer K; Niederle B
    Endocr Relat Cancer; 2010 Dec; 17(4):909-18. PubMed ID: 20702725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications.
    Strosberg JR; Cheema A; Weber JM; Ghayouri M; Han G; Hodul PJ; Kvols LK
    Ann Surg; 2012 Aug; 256(2):321-5. PubMed ID: 22415420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic features of rectal neuroendocrine tumors.
    Weinstock B; Ward SC; Harpaz N; Warner RR; Itzkowitz S; Kim MK
    Neuroendocrinology; 2013; 98(3):180-7. PubMed ID: 24080744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in TNM staging of pulmonary neuroendocrine tumors requires histology and regrouping of tumor size.
    Cattoni M; Vallières E; Brown LM; Sarkeshik AA; Margaritora S; Siciliani A; Filosso PL; Guerrera F; Imperatori A; Rotolo N; Farjah F; Wandell G; Costas K; Mann C; Hubka M; Kaplan S; Farivar AS; Aye RW; Louie BE
    J Thorac Cardiovasc Surg; 2018 Jan; 155(1):405-413. PubMed ID: 28986041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems.
    Clift AK; Faiz O; Goldin R; Martin J; Wasan H; Liedke MO; Schloericke E; Malczewska A; Rindi G; Kidd M; Modlin IM; Frilling A
    Endocr Connect; 2017 Feb; 6(2):71-81. PubMed ID: 28104724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for disease relapse in patients with neuroendocrine tumours who underwent curative surgery.
    Slagter AE; Ryder D; Chakrabarty B; Lamarca A; Hubner RA; Mansoor W; O'Reilly DA; Fulford PE; Klümpen HJ; Valle JW; McNamara MG
    Surg Oncol; 2016 Sep; 25(3):223-8. PubMed ID: 27566026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.
    Rindi G; Falconi M; Klersy C; Albarello L; Boninsegna L; Buchler MW; Capella C; Caplin M; Couvelard A; Doglioni C; Delle Fave G; Fischer L; Fusai G; de Herder WW; Jann H; Komminoth P; de Krijger RR; La Rosa S; Luong TV; Pape U; Perren A; Ruszniewski P; Scarpa A; Schmitt A; Solcia E; Wiedenmann B
    J Natl Cancer Inst; 2012 May; 104(10):764-77. PubMed ID: 22525418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
    Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
    Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the prognostic values of the 2010 WHO classification, AJCC 7th edition, and ENETS classification of gastric neuroendocrine tumors.
    Kim BS; Park YS; Yook JH; Kim BS
    Medicine (Baltimore); 2016 Jul; 95(30):e3977. PubMed ID: 27472674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital.
    Folkestad O; Wasmuth HH; Mjønes P; Fougner R; Hauso Ø; Fossmark R
    Surg Oncol; 2020 Dec; 35():336-343. PubMed ID: 32979699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology - grading and staging of GEP-NETs.
    Capelli P; Fassan M; Scarpa A
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):705-17. PubMed ID: 23582914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine tumors of the colon and rectum: prognostic relevance and comparative performance of current staging systems.
    Chagpar R; Chiang YJ; Xing Y; Cormier JN; Feig BW; Rashid A; Chang GJ; You YN
    Ann Surg Oncol; 2013 Apr; 20(4):1170-8. PubMed ID: 23212760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasms.
    Zhang Y; Shang L; Zhang PP; Chen LH; Wang W; Fang C; Qiu M; Feng XY; Zhou L; Zhang M; Tan HY; Qiu XD; Wang H; Lin R; Zhang Q; Zeng YJ; Jin KZ; Yu XJ; Shen L; Chen MH; Li J; Li LP; Chen J
    Cancer Med; 2019 Sep; 8(11):5000-5011. PubMed ID: 31293053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroenteric neuroendocrine neoplasms classification: comparison of prognostic models.
    Dolcetta-Capuzzo A; Villa V; Albarello L; Franchi GM; Gemma M; Scavini M; Di Palo S; Orsenigo E; Bosi E; Doglioni C; Manzoni MF
    Cancer; 2013 Jan; 119(1):36-44. PubMed ID: 22744914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors: A Retrospective Nationwide Multicenter Study in South Korea.
    Cho JH; Ryu JK; Song SY; Hwang JH; Lee DK; Woo SM; Joo YE; Jeong S; Lee SO; Park BK; Cheon YK; Han J; Kim TN; Lee JK; Moon SH; Kim H; Park ET; Hwang JC; Kim TH; Jeon TJ; Cho CM; Choi HS; Lee WJ
    Pancreas; 2016 Aug; 45(7):941-6. PubMed ID: 26765964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Trends in Patients with Small Intestinal Neuroendocrine Tumours-A Cohort Study in Central Norway.
    Folkestad O; Hauso Ø; Mjønes P; Fougner R; Wasmuth HH; Fossmark R
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Best prognostic factor of neuroendocrine tumors: Grade or Stage? A multidisciplinary single-center study.
    Özaslan E; Bayram F; Karaca H; Gürsoy Ş; Öztürk F; Sözüer E; Abdurrezzak Ü; Yurci A; Can Sezgin G; Yıldırım A; Başpınar O; Kula M; Özkan M
    Turk J Gastroenterol; 2016 Nov; 27(6):509-514. PubMed ID: 27852541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.